Resultados de la búsqueda 451-460 of 1834 for Threadworm

  1. Hematología y oncología pediátrica - Ensayos clínicos

    Rochester, Minn. This protocol is being designed to offer testicular tissue cryopreservation to male pediatric patients (0-17 years of age) with fertility ...

  2. Hemorroides - Mayo Clinic

    Las hemorroides son venas hinchadas en la parte inferior del recto. Las hemorroides que se encuentran dentro del recto suelen ser indoloras, pero tienden a ...

  3. Oncología (médica) - Ensayos clínicos

    Effective treatments for recurrent gynecological cancer are lacking, and there is a need for novel therapeutic options. One of the barriers to improving ...

  4. Oncología (médica) - Ensayos clínicos

    The purpose of this study is to evaluate immune profile of Acute Myeloid Leukemia (AML) patients receiving Venetoclax plus Azacitidine induction chemotherapy.

  5. Hematología - Ensayos clínicos

    This phase II trial studies how well sapanisertib works in treating patients with pancreatic neuroendocrine tumor that has spread to other places in the ...

  6. Oncología (médica) - Ensayos clínicos

    This phase II trial tests how well turkey tail mushroom (TTM) works in treating post-menopausal women with HER2-negative, estrogen receptor (ER)-positive breast ...

  7. Tiña (en el cuero cabelludo) - Síntomas y causas - Mayo Clinic

    Zonas de calvicie que se agrandan lentamente y tienen pequeños puntos negros donde el cabello se desprendió. Cabello quebradizo o frágil que se puede romper o ...

  8. Hematología - Ensayos clínicos

    Chemotherapy drugs, such as CC-486, cyclophosphamide, doxorubicin, vincristine, etoposide and prednisone, work in different ways to stop the growth of cancer ...

  9. Oncología (médica) - Ensayos clínicos

    Immunotherapy with monoclonal antibodies, such as durvalumab, may help the body's immune system attack the cancer, and may interfere with the ability of tumor ...

  10. Ensayos clínicos - Hematología

    Venetoclax may stop the growth of cancer cells by blocking Bcl-2, a protein needed for cancer cell survival. Giving venetoclax with ibrutinib and rituximab with ...